Anixa Biosciences Inc
(ANIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2015 | 10-2014 | 10-2013 | 10-2012 | 10-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,379 | -9,606 | -10,080 | -4,253 | -7,378 |
| Depreciation Amortization | 790 | 1,335 | 991 | N/A | 8 |
| Accounts receivable | 400 | -225 | -175 | N/A | N/A |
| Other Working Capital | -882 | -394 | 130 | -752 | 2,184 |
| Other Operating Activity | 2,434 | 6,512 | 5,947 | 1,864 | 4,471 |
| Operating Cash Flow | $1,363 | $-2,379 | $-3,187 | $-3,141 | $-716 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,000 | -2,500 | 500 | 1,749 | -2,248 |
| PPE Investments | -55 | -7 | N/A | N/A | -9 |
| Net Acquisitions | -2,900 | N/A | N/A | N/A | 119 |
| Other Investing Activity | 0 | 0 | -1 | -1 | 0 |
| Investing Cash Flow | $45 | $-2,507 | $499 | $1,748 | $-2,138 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,500 | 1,765 | 750 | N/A |
| Debt Repayment | N/A | -200 | N/A | N/A | N/A |
| Common Stock Issued | 45 | 4,049 | 1,481 | 209 | 2,534 |
| Common Stock Repurchased | -445 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-401 | $7,349 | $3,246 | $959 | $2,534 |
| Beginning Cash Position | 3,361 | 898 | 340 | 774 | 1,094 |
| End Cash Position | 4,369 | 3,361 | 898 | 340 | 774 |
| Net Cash Flow | $1,008 | $2,463 | $559 | $-434 | $-320 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,363 | -2,379 | -3,187 | -3,141 | -716 |
| Capital Expenditure | -55 | -7 | N/A | N/A | -9 |
| Free Cash Flow | 1,309 | -2,386 | -3,187 | -3,141 | -725 |